According to a report by Intel Market Research, the global Blood Transfusion Market was valued at USD 86 million in 2025, is estimated to reach USD 89 million in 2026, and is projected to reach USD 123 million by 2034, representing a 4.1% CAGR during 2026–2034. The study covers single-use blood-transfusion administration sets and related configurations used to deliver whole blood or blood components from a container to patients. The market encompasses Y-type, straight and other specialty sets across child and adult patient populations.
Explore the full report: https://www.intelmarketresearch.com/blood-transfusion-market-market-13552
Why Is Demand Increasing?
- Large transfusion-care volumes: The World Health Organization reports 120.4 million blood donations globally, creating a substantial procedural base for recurring consumption of sterile administration sets across surgery, trauma, oncology, hematology and critical care.
- Stronger blood-safety systems: WHO reports that 79% of reporting countries had a national blood policy, while 71% had specific blood-safety legislation in its 2026 global assessment. These frameworks increase requirements for validated materials, traceability, sterility documentation and consistent product quality.
- Blood-centre automation: Automated component-processing systems are changing blood-centre workflows. Terumo Blood and Cell Technologies’ Reveos platform can separate whole blood into platelets, plasma and red-cell concentrates in a single automated centrifugation cycle, increasing the importance of compatible downstream administration products.
Blood Technology & Patient Safety Watch
The blood transfusion industry is increasingly moving toward standardized, traceable and technology-enabled workflows. Automated blood-component processing, digital blood-centre data and pathogen-reduction systems are raising expectations around product compatibility and process consistency. The report also highlights closed single-use delivery systems as an area where manufacturers can differentiate through safety, materials, ergonomics and simplified clinical handling. Another development is the expansion of emergency transfusion capability following the U.S. FDA’s July 2026 licensing of EZPLAZ, the first freeze-dried plasma product licensed in the United States. While the development does not directly translate one-for-one into transfusion-set revenue, it creates additional operational relevance for dependable administration products in emergency, remote and austere environments.
Segmentation Highlights
- By Type: The market is segmented into Y-type, Straight and Other transfusion sets. Y-type sets hold the leading position because their branching configuration provides flexible access for blood components and compatible fluids across surgery, emergency and critical-care workflows.
- By End User: The report analyzes Child and Adult patient populations. Adult care represents the broader procedural demand base, spanning surgery, trauma, oncology, hematology, gastrointestinal bleeding and critical care.
- Specialized configurations: Other set formats address pediatric, high-flow and institution-specific requirements where tubing length, connector design, filtration or handling characteristics may require differentiated products.
Regional Outlook
- North America: North America is the largest regional market in 2025, supported by high hospital procedure intensity, stringent oversight and early adoption of automated blood-processing and advanced transfusion-safety technologies.
- Europe: Europe remains an important regulatory and blood-technology hub, characterized by mature national blood services, high component-processing standards and strong regulatory expectations. England recorded 1,492,302 blood and platelet donations in 2024, demonstrating the scale of its organized donor system.
- Asia-Pacific: Asia-Pacific presents substantial volume opportunities as national blood systems expand collection and standardization. India and China provide large-volume opportunities, while Japan and Australia support higher-value safety and quality specifications.
- India: India’s annual blood collection increased from 12.6 million units in 2023 to 14.6 million units in 2024, with voluntary donation accounting for 74.55% of collection.
- Latin America and Middle East & Africa: Brazil anchors Latin American demand, while Gulf markets support higher-specification hospital procurement. Many African markets continue to emphasize donor recruitment, basic access and dependable low-cost supplies.
Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/13552/blood-transfusion-market-market
Why This Market Matters
Blood-transfusion administration sets are relatively simple single-use products, but their role within safety-critical clinical workflows makes reliability, sterility, traceability and compatibility increasingly important. Hospitals and blood services must maintain dependable inventories for surgery, trauma, oncology, hematology and intensive-care requirements while managing procurement costs and transfusion efficiency.
The market is also being influenced by modernization across the broader blood-management ecosystem. Automated component processing, pathogen-reduction workflows, digital data capture and emergency plasma technologies are changing how blood products are collected, processed and delivered. This creates opportunities for suppliers that can integrate dependable administration products into standardized and increasingly technology-enabled transfusion pathways.
Competitive Landscape
- B. Braun Melsungen AG — Competes through hospital consumables, infusion expertise and established institutional contracting relationships.
- Terumo Blood and Cell Technologies — Competes through blood collection, component processing, automation and blood-management technologies.
- Grifols S.A. — Participates across plasma and blood-system activities, bringing expertise in component handling and blood-centre operations.
- Fresenius Kabi — Competes through its broad hospital-product portfolio and transfusion-related consumables.
- Haemonetics Corporation — Participates in blood-management technologies, automation and transfusion workflows.
View the full report: https://www.intelmarketresearch.com/blood-transfusion-market-market-13552
FAQ
Q: What is the Blood Transfusion Market size and forecast?
A: The market was valued at USD 86 million in 2025, is estimated at USD 89 million in 2026, and is projected to reach USD 123 million by 2034, representing a 4.1% CAGR during 2026–2034.
Q: Which region leads the Blood Transfusion Market?
A: North America is the largest regional market in 2025, while Europe remains an important manufacturing and regulatory hub and Asia-Pacific offers substantial volume opportunities.
Q: Which product segment leads the market?
A: Y-type transfusion sets hold the leading position by type because their branching configuration supports flexible administration across surgery, trauma, intensive care and other clinical settings.
What Does the Full Report Cover?
The full study provides a detailed view of the Blood Transfusion Market across Y-type, straight and other administration sets, together with child and adult end-user demand. It covers the 2025 base year, 2026 estimate and 2026–2034 forecast period, with analysis across North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. Country coverage includes the United States, Canada, Mexico, Germany, France, the United Kingdom, Italy, China, Japan, India, South Korea, Brazil, Saudi Arabia and South Africa. The study also examines transfusion volumes, blood-safety requirements, automation, procurement pressures, component processing, traceability, pathogen-reduction workflows and emergency transfusion readiness.
View the complete report: https://www.intelmarketresearch.com/blood-transfusion-market-market-13552
Download the free sample: https://www.intelmarketresearch.com/download-free-sample/13552/blood-transfusion-market-market
Related Reports
The supplied IMR report page does not provide verified related-report URLs. No unverified links have been added.
About Intel Market Research
Intel Market Research is a leading provider of strategic intelligence, offering actionable insights across biotechnology, pharmaceuticals and healthcare infrastructure. Its research supports organizations with market intelligence, competitive analysis, forecasting and industry-focused research.
Contact Details
Website: www.intelmarketresearch.com
Asia-Pacific: +91 9169164321
